These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 33324345

  • 1. Repression of MicroRNA-124-3p Alleviates High-Fat Diet-Induced Hepatosteatosis by Targeting Pref-1.
    Wang G, Zou H, Lai C, Huang X, Yao Y, Xiang G.
    Front Endocrinol (Lausanne); 2020; 11():589994. PubMed ID: 33324345
    [Abstract] [Full Text] [Related]

  • 2. A negative feedback loop between microRNA-378 and Nrf1 promotes the development of hepatosteatosis in mice treated with a high fat diet.
    Zhang T, Zhao X, Steer CJ, Yan G, Song G.
    Metabolism; 2018 Aug; 85():183-191. PubMed ID: 29625129
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-137-3p Improves Nonalcoholic Fatty Liver Disease through Activating AMPKα.
    Yu Y, He C, Tan S, Huang M, Guo Y, Li M, Zhang Q.
    Anal Cell Pathol (Amst); 2021 Aug; 2021():4853355. PubMed ID: 35004133
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-376b-3p ameliorates nonalcoholic fatty liver disease by targeting FGFR1 and regulating lipid oxidation in hepatocytes.
    Wang XY, Lu LJ, Li YM, Xu CF.
    Life Sci; 2022 Nov 01; 308():120925. PubMed ID: 36057399
    [Abstract] [Full Text] [Related]

  • 5. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
    Hur W, Lee JH, Kim SW, Kim JH, Bae SH, Kim M, Hwang D, Kim YS, Park T, Um SJ, Song BJ, Yoon SK.
    Int J Biochem Cell Biol; 2015 Jul 01; 64():265-76. PubMed ID: 25957914
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MicroRNA-194 inhibition improves dietary-induced non-alcoholic fatty liver disease in mice through targeting on FXR.
    Nie H, Song C, Wang D, Cui S, Ren T, Cao Z, Liu Q, Chen Z, Chen X, Zhou Y.
    Biochim Biophys Acta Mol Basis Dis; 2017 Dec 01; 1863(12):3087-3094. PubMed ID: 28951211
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long non-coding RNA GAS5 contributes to the progression of nonalcoholic fatty liver disease by targeting the microRNA-29a-3p/NOTCH2 axis.
    Cui J, Wang Y, Xue H.
    Bioengineered; 2022 Apr 01; 13(4):8370-8381. PubMed ID: 35322757
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MicroRNA-27a regulates hepatic lipid metabolism and alleviates NAFLD via repressing FAS and SCD1.
    Zhang M, Sun W, Zhou M, Tang Y.
    Sci Rep; 2017 Nov 03; 7(1):14493. PubMed ID: 29101357
    [Abstract] [Full Text] [Related]

  • 16. Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease.
    Shan W, Gao L, Zeng W, Hu Y, Wang G, Li M, Zhou J, Ma X, Tian X, Yao J.
    Cell Death Dis; 2015 Jul 23; 6(7):e1833. PubMed ID: 26203862
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Upregulation of miR-125b by estrogen protects against non-alcoholic fatty liver in female mice.
    Zhang ZC, Liu Y, Xiao LL, Li SF, Jiang JH, Zhao Y, Qian SW, Tang QQ, Li X.
    J Hepatol; 2015 Dec 23; 63(6):1466-75. PubMed ID: 26272872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.